These redox-dependent transitions underscore that HMGB1’s extracellular functions are not uniform but dynamically shaped by oxidative stress, therapy-induced cell death, and the tumor microenvironment, influencing whether HMGB1 promotes antitumor immunity or contributes to resistance-associated inflammation. Here, HMGB1 is linked to neoplasm.